Literature DB >> 26239693

Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".

Åke Bergman1, Georg Becher2, Bruce Blumberg3, Poul Bjerregaard4, Riana Bornman5, Ingvar Brandt6, Stephanie C Casey3, Heloise Frouin7, Linda C Giudice8, Jerrold J Heindel9, Taisen Iguchi10, Susan Jobling11, Karen A Kidd12, Andreas Kortenkamp11, P Monica Lind6, Derek Muir13, Roseline Ochieng14, Erik Ropstad15, Peter S Ross7, Niels Erik Skakkebaek16, Jorma Toppari17, Laura N Vandenberg18, Tracey J Woodruff8, R Thomas Zoeller18.   

Abstract

We present a detailed response to the critique of "State of the Science of Endocrine Disrupting Chemicals 2012" (UNEP/WHO, 2013) by financial stakeholders, authored by Lamb et al. (2014). Lamb et al.'s claim that UNEP/WHO (2013) does not provide a balanced perspective on endocrine disruption is based on incomplete and misleading quoting of the report through omission of qualifying statements and inaccurate description of study objectives, results and conclusions. Lamb et al. define extremely narrow standards for synthesizing evidence which are then used to dismiss the UNEP/WHO 2013 report as flawed. We show that Lamb et al. misuse conceptual frameworks for assessing causality, especially the Bradford-Hill criteria, by ignoring the fundamental problems that exist with inferring causality from empirical observations. We conclude that Lamb et al.'s attempt of deconstructing the UNEP/WHO (2013) report is not particularly erudite and that their critique is not intended to be convincing to the scientific community, but to confuse the scientific data. Consequently, it promotes misinterpretation of the UNEP/WHO (2013) report by non-specialists, bureaucrats, politicians and other decision makers not intimately familiar with the topic of endocrine disruption and therefore susceptible to false generalizations of bias and subjectivity.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  EDCs; Endocrine disruption; Endocrine disruptors

Mesh:

Substances:

Year:  2015        PMID: 26239693     DOI: 10.1016/j.yrtph.2015.07.026

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  21 in total

1.  Sex- and age-dependent effects of maternal organophosphate flame-retardant exposure on neonatal hypothalamic and hepatic gene expression.

Authors:  Samantha Adams; Kimberly Wiersielis; Ali Yasrebi; Kristie Conde; Laura Armstrong; Grace L Guo; Troy A Roepke
Journal:  Reprod Toxicol       Date:  2020-04-29       Impact factor: 3.143

Review 2.  Peer-reviewed and unbiased research, rather than 'sound science', should be used to evaluate endocrine-disrupting chemicals.

Authors:  Leonardo Trasande; Laura N Vandenberg; Jean-Pierre Bourguignon; John Peterson Myers; Remy Slama; Frederick Vom Saal; Robert Thomas Zoeller
Journal:  J Epidemiol Community Health       Date:  2016-07-13       Impact factor: 3.710

Review 3.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

4.  There are good clinical, scientific, and social reasons to strengthen links between biomedical and environmental research.

Authors:  Miquel Porta; Laura N Vandenberg
Journal:  J Clin Epidemiol       Date:  2019-03-21       Impact factor: 6.437

Review 5.  The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders.

Authors:  Milica Medic Stojanoska; Natasa Milosevic; Natasa Milic; Ludovico Abenavoli
Journal:  Endocrine       Date:  2016-11-07       Impact factor: 3.633

6.  Clarity in the face of confusion: new studies tip the scales on bisphenol A (BPA).

Authors:  L N Vandenberg; G S Prins
Journal:  Andrology       Date:  2016-05-17       Impact factor: 3.842

Review 7.  Methodological issues in human studies of endocrine disrupting chemicals.

Authors:  Duk-Hee Lee; David R Jacobs
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

Review 8.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

Review 9.  Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals.

Authors:  Anna Beronius; Laura N Vandenberg
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

Review 10.  Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies.

Authors:  Ana López-Moreno; Inmaculada Acuña; Alfonso Torres-Sánchez; Ángel Ruiz-Moreno; Klara Cerk; Ana Rivas; Antonio Suárez; Mercedes Monteoliva-Sánchez; Margarita Aguilera
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.